Related Experiment Video
Updated: Jun 27, 2025

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Donor heart refusal after circulatory death: An analysis of United Network for Organ Sharing refusal codes
Tyler M Dann1,2, Brianna L Spencer1,2, Spencer K Wilhelm1,2
1Department of Surgery, University of Michigan Medical School, Ann Arbor, Mich.
Insights
Donor hearts after circulatory death (DCD) are declined more often than brain-dead donor (DBD) hearts due to concerns about prolonged dying and organ preservation. Improving DCD heart transplantation requires addressing these preservation issues.
Area of Science:
- Cardiology
- Transplantation Medicine
- Organ Donation
Background:
- Donor hearts procured after circulatory death (DCD) offer a potential to increase heart availability for transplantation.
- Understanding DCD heart utilization and refusal patterns is crucial for optimizing the donor pool.
Purpose of the Study:
- To analyze current heart transplantation rates for DCD and brain-dead donors (DBD).
- To characterize organ refusal patterns for DCD hearts using recent national data.
Main Methods:
- Analysis of United Network for Organ Sharing (UNOS) and Organ Procurement and Transplantation Network (OPTN) data from 2020-2022.
- Examination of DCD and DBD candidate, transplantation, and demographic data.
- Characterization of DCD refusal codes and regional transplantation rate variations.
Main Results:
- DCD hearts were declined 3.37 times more frequently than DBD hearts.
- Primary reasons for DCD refusal included neurologic function (92% in 2022), prolonged warm ischemic time, and organ preservation concerns.
- Significant variation in transplantation rates was observed across demographic groups and UNOS regions.
Conclusions:
- DCD donor hearts face higher refusal rates compared to DBD hearts, primarily due to concerns regarding the dying process and organ preservation.
- Strategies such as ex situ hemodynamic assessment and normothermic regional perfusion guidelines may enhance DCD heart transplantation rates.
Objective:
Donor hearts procured after circulatory death (DCD) may significantly increase the number of hearts available for transplantation. The purpose of this study was to analyze current DCD and brain-dead donor (DBD) heart transplantation rates and characterize organ refusal using the most up-to-date United Network for Organ Sharing (UNOS) and Organ Procurement and Transplantation Network data.
Methods:
We analyzed UNOS and Organ Procurement and Transplantation Network DBD and DCD candidate, transplantation, and demographic data from 2020 through 2022 and 2022 refusal code data to characterize DCD heart use and refusal. Subanalyses were performed to characterize DCD donor demographics and regional transplantation rate variance.
Results:
DCD hearts were declined 3.37 times more often than DBD hearts. The most frequently used code for DCD refusal was neurologic function, related to concerns of a prolonged dying process and organ preservation. In 2022, 92% (1329/1452) of all DCD refusals were attributed to neurologic function. When compared with DBD, DCD donor hearts were more frequently declined as the result of prolonged warm ischemic time (odds ratio, 5.65; 95% confidence interval, 4.07-7.86) and other concerns over organ preservation (odds ratio, 4.06; 95% confidence interval, 3.33-4.94). Transplantation rate variation was observed between demographic groups and UNOS regions. DCD transplantation rates are currently experiencing second order polynomial growth.
Conclusions:
DCD donor hearts are declined more frequently than DBD. DCD heart refusals result from concerns over a prolonged dying process and organ preservation. Heart transplantation rates may be substantially improved by ex situ hemodynamic assessment, adoption of normothermic regional perfusion guidelines, and quality initiatives.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

